Influence of wall motion score on mortality after coronary bypass surgery in the CABG-patch trial-Reference-Cited by-同舟云学术

Influence of wall motion score on mortality after coronary bypass surgery in the CABG-patch trial

Published:2002-01 Issue:1 Volume:82 Page:41-47
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Jung Frank,Herre John M,Wood Mark A,O’Donoghue Susan,Cannom David S,Windle John R,Hilbel Thomas,Talreja Deepak R,Parides Michael K,Bigger J.Thomas,DiMarco John P

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference26 articles.

1. Mortality and morbidity after coronary artery bypass surgery related to pre-operative left ventricular ejection fraction: a follow-up study;Risum;Eur Heart J,1996

2. Risk factors for early and late mortality in surgical treatment of coronary artery disease;Risum;Cardiovasc Surg,1995

3. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators;Bigger;New Engl J Med,1997

4. A randomized trial of coronary artery bypass surgery. Survival of patients with a low ejection fraction;Passamani;New Engl J Med,1985

5. Early and long-term results of coronary artery bypass grafting with severely depressed left ventricular performance;Freeman;Am J Cardiol,1984

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HRS/ACC/AHA Expert Consensus Statement on the Use of Implantable Cardioverter-Defibrillator Therapy in Patients Who Are Not Included or Not Well Represented in Clinical Trials;Journal of the American College of Cardiology;2014-09

2. HRS/ACC/AHA Expert Consensus Statement on the Use of Implantable Cardioverter-Defibrillator Therapy in Patients Who Are Not Included or Not Well Represented in Clinical Trials;Heart Rhythm;2014-07

3. HRS/ACC/AHA Expert Consensus Statement on the Use of Implantable Cardioverter-Defibrillator Therapy in Patients Who Are Not Included or Not Well Represented in Clinical Trials;Circulation;2014-07